These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 26810552)
1. Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products. Awasthi M; Singh S; Pandey VP; Dwivedi UN J Neurol Sci; 2016 Feb; 361():256-71. PubMed ID: 26810552 [TBL] [Abstract][Full Text] [Related]
4. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide. Drew SC; Barnham KJ Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485 [TBL] [Abstract][Full Text] [Related]
5. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease. Savelieff MG; DeToma AS; Derrick JS; Lim MH Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056 [TBL] [Abstract][Full Text] [Related]
6. Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets. Han SH; Park JC; Mook-Jung I Prog Neurobiol; 2016 Feb; 137():17-38. PubMed ID: 26721621 [TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and Therapeutic Strategies in Alzheimer's Disease: From Brain to Periphery. Yu JT; Zhang C Neurotox Res; 2016 Feb; 29(2):197-200. PubMed ID: 26597964 [TBL] [Abstract][Full Text] [Related]
9. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis. Castello MA; Soriano S Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390 [TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic implications of gelsolin in Alzheimer's disease. Ji L; Zhao X; Hua Z J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622 [TBL] [Abstract][Full Text] [Related]
11. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease. Villemagne VL; Rowe CC J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919 [TBL] [Abstract][Full Text] [Related]
12. The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease. Ling S; Zhou J; Rudd JA; Hu Z; Fang M Anat Rec (Hoboken); 2011 Aug; 294(8):1307-18. PubMed ID: 21717585 [TBL] [Abstract][Full Text] [Related]
14. Understanding the cause of sporadic Alzheimer's disease. Zetterberg H; Mattsson N Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227 [TBL] [Abstract][Full Text] [Related]
15. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease. Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539 [TBL] [Abstract][Full Text] [Related]
16. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease. Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982 [TBL] [Abstract][Full Text] [Related]
17. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms. Hampel H J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423 [TBL] [Abstract][Full Text] [Related]
18. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease. Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767 [TBL] [Abstract][Full Text] [Related]
19. Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians. Asih PR; Chatterjee P; Verdile G; Gupta VB; Trengove RD; Martins RN Neurodegener Dis Manag; 2014; 4(5):363-78. PubMed ID: 25405650 [TBL] [Abstract][Full Text] [Related]
20. Natural Products based P-glycoprotein Activators for Improved β-amyloid Clearance in Alzheimer's Disease: An in silico Approach. Shinde P; Vidyasagar N; Dhulap S; Dhulap A; Hirwani R Cent Nerv Syst Agents Med Chem; 2015; 16(1):50-9. PubMed ID: 26306632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]